Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway
Overexpressed survivin is associated with worse survival of several types of human tumors. In this study, the antitumor activity of shikonin in non-small-cell lung cancer (NSCLC) by regulating survivin pathway was investigated. Results showed that shikonin inhibited the NSCLC H1299 cell proliferatio...
Saved in:
Main Authors: | Haini Wang, Junli Zuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2021/6435393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway
by: Tong Liu, et al.
Published: (2016-01-01) -
Survivin is Highly Expressed and Promotes Cell Survival in Malignant Peritoneal Mesothelioma
by: Nadia Zaffaroni, et al.
Published: (2007-01-01) -
CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
by: Qian Dai, et al.
Published: (2024-12-01) -
Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer
by: Xinhang Xia, et al.
Published: (2022-01-01) -
Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway
by: Punnida Arjsri, et al.
Published: (2025-01-01)